© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Sydney Jennings
Articles
Measles Outbreak Fails to Push MMR Rates to Herd Immunity Levels, Study Reveals
September 30, 2025
Measles vaccine coverage must reach 93% to maintain herd immunity but in 1 postelimination outbreak, the level reached only 80% in school-aged children.
FDA Approves Guselkumab for Pediatric Plaque Psoriasis and Active Psoriatic Arthritis
September 30, 2025
The FDA has approved guselkumab for children aged 6 years and older with moderate to severe plaque psoriasis or active psoriatic arthritis, making it the first IL-23 inhibitor authorized for pediatric use.
Approximately Half of People with Diabetes Worldwide Unaware They Have the Disease: Daily Dose
September 30, 2025
Your daily dose of the clinical news you may have missed.
Planning to Attend FMX 2025, October 5-9? What Family Physicians Can Expect in Anaheim
September 29, 2025
The annual meeting of the American Academy of Family Physicians is a unique chance to choose continuing education on just about any topic a family physician could imagine.
10 Drugs Approved for Primary Care From the First Half of 2025
September 29, 2025
Review FDA-approved drugs that may soon find a place in your prescribing routine, including new treatments for UTIs, acute pain, migraine, diabetes, and more.
Donanemab (Kisunla) Authorized in Europe for Early Symptomatic Alzheimer Disease
September 29, 2025
The European Commission granted marketing authorization for the Lilly mAb based on data from the phase 3 TRAILBLAZER-ALZ 2 and 6 clinical trials.
Novo Nordisk Resubmits Insulin Icodec Injection to FDA for Potential First Once-Weekly Basal Insulin Therapy for T2D
September 29, 2025
Novo Nordisk aims to revolutionize diabetes care with its resubmission for insulin icodec, a potential first once-weekly basal insulin for type 2 diabetes therapy in adults.
RSV Vaccines Found Safe and Effective Across High-Risk Groups in Cochrane Review
September 29, 2025
Vaccines for respiratory syncytial virus were found both safe and effective across 100,000 participants and, critically, for older adults and infants.
Preconception CT Scans Tied to Higher Risk of Pregnancy Loss, Congenital Anomalies: Daily Dose
September 29, 2025
Your daily dose of the clinical news you may have missed.